CRI9
Product Specifications
UNSPSC Description
CRI9 inhibits the c-MET/PI3K/Akt/mTOR pathway, suppressing the growth of liver cancer cells. CRI9 shows strong cytotoxicity against HCC cells, inducing apoptosis[1].
Target Antigen
Akt; Apoptosis; c-Met/HGFR; mTOR; PI3K
Type
Reference compound
Related Pathways
Apoptosis;PI3K/Akt/mTOR;Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cri9.html
Smiles
O=C(C1=CC=CC=C1N/2)C2=C3C(N(CC4=CN(C5=CC([N+]([O-])=O)=CC=C5C)N=N4)C6=C\3C=CC=C6)=O
Molecular Weight
478.46
References & Citations
[1]Shalini V Gowda, et al. A new 1,2,3-triazole-indirubin hybrid suppresses tumor growth and pulmonary metastasis by mitigating the HGF/c-MET axis in hepatocellular carcinoma. J Adv Res. 2024 Aug 30:S2090-1232(24)00377-1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-168609/CRI9-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-168609/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E01C1695-01 48 Well
Human Cysteine and histidine rich domain containing protein 1 (CHORDC1) ELISA Kit
Ask
View Details E01C1695-02 96 Well
Human Cysteine and histidine rich domain containing protein 1 (CHORDC1) ELISA Kit
Ask
View Details 
QP8339-ec-500ug 500ug
Recombinant Human Rab GDP dissociation inhibitor beta Protein, GST, E.coli-500ug
Ask
View Details